Skip to main content

Table 1 General data of patients in PE-PLIF group and MPLIF group

From: Clinical efficacy of percutaneous endoscopic posterior lumbar interbody fusion and modified posterior lumbar interbody fusion in the treatment of lumbar degenerative disease

 

PE-PLIF (n = 37)

MPLIF(n = 58)

P

Sex (Male/Female)

22/15

26/32

0.164

Age (years)

56 (51.5, 63)

58.5 (51, 65.25)

0.691

Disease type

   

 LS

26

30

0.073

 LSS

11

28

Surgical level

   

 L3/4

8

7

0.461

 L4/5

16

28

 L5/S1

13

23

 Follow-up time (months)

15 (13.5, 16)

15 (14,16)

0.576